SEC Filings

S-1/A
AVEXIS, INC. filed this Form S-1/A on 02/01/2016
Entire Document
 

Table of Contents

Mr. Dee

          We entered into an employment agreement with Mr. Dee, our Chief Financial Officer, in July 2015. Pursuant to the terms of his employment agreement, Mr. Dee's employment is at will and may be terminated at any time by us or Mr. Dee. Under the terms of the agreement, Mr. Dee is entitled to receive an annual base salary of $350,000 and an annual target bonus of 40% of his annual base salary based upon our board of directors' assessment of Mr. Dee's performance and our attainment of targeted goals as set by the board of directors in their sole discretion. In accordance with the agreement, Mr. Dee was also granted an option to purchase 164,059 shares of our common stock. 25% of the shares subject to the option vest on August 3, 2016 (the first anniversary of Mr. Dee's commencement of employment) and the remaining shares vest in 36 equal monthly installments thereafter, subject to Mr. Dee's continued service and subject to full acceleration upon the occurrence of a sale event, as defined in Mr. Dee's agreement. Pursuant to his agreement, Mr. Dee also entered into a confidentiality, inventions assignment, non-competition and non-solicitation agreement with us.

Dr. Nagendran

          We entered into an employment agreement with Dr. Nagendran, our Senior Vice President and Chief Medical Officer, in August 2015. Pursuant to the terms of his employment agreement, Dr. Nagendran's employment is at will and may be terminated at any time by us or Dr. Nagendran. Under the terms of the agreement, Dr. Nagendran is entitled to receive an annual base salary of $395,000, a one-time sign-on bonus of $75,000 and an annual target bonus of 40% of his annual base salary based upon our board of directors' assessment of Dr. Nagendran's performance and our attainment of targeted goals as set by the board of directors in their sole discretion. We have agreed to pay Dr. Nagendran 100% of the full year target bonus of 40% of his annual base salary for the 2015 calendar year. In accordance with the agreement, Dr. Nagendran was also granted an option to purchase 199,855 shares of our common stock. 25% of the shares subject to the option vest on September 14, 2016 (the first anniversary of Dr. Nagendran's commencement of employment) and the remaining shares vest in 36 equal monthly installments thereafter, subject to Dr. Nagendran's continued service and subject to full acceleration upon the occurrence of a sale event, as defined in Dr. Nagendran's agreement. Additionally, Dr. Nagendran is entitled to a monthly relocation allowance of $3,500 for the first 36 months of his continued employment with us. Pursuant to his agreement, Dr. Nagendran also entered into a confidentiality, inventions assignment, non-competition and non-solicitation agreement with us.

Dr. L'Italien

          We entered into an employment agreement with Dr. L'Italien, our Chief Regulatory and Quality Officer, in July 2015. Pursuant to the terms of his employment agreement, Dr. L'Italien's employment is at will and may be terminated at any time by us or Dr. L'Italien. Under the terms of the agreement, Dr. L'Italien is entitled to receive an annual base salary of $365,000 and an annual target bonus of 40% of his annual base salary based upon our board of directors' assessment of Dr. L'Italien's performance and our attainment of targeted goals as set by the board of directors in their sole discretion. Dr. L'Italien is eligible to receive up to 50% of the full year target bonus of 40% of his annual base salary for the 2015 calendar year. In accordance with the agreement, Dr. L'Italien was also granted an option to purchase 151,800 shares of our common stock. 25% of the shares subject to the option vest on July 20, 2016 (the first anniversary of Dr. L'Italien's commencement of employment) and the remaining shares vest in 36 equal monthly installments thereafter, subject to Dr. L'Italien's continued service and subject to full acceleration upon the occurrence of a sale event, as defined in Dr. L'Italien's agreement. Additionally, Dr. L'Italien's agreement provides for a one-time relocation allowance of $36,500, which is subject to repayment if Dr. L'Italien's employment is terminated for cause or if Dr. L'Italien resigns, each within one year following the commencement of

155



© AveXis, Inc. All Rights Reserved.